logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Candidiasis Of Esophagus

    FiltersReset Filters
    7 results

    • fluconazole

      (Fluconazole)
      BluePoint Laboratories
      Usage: Fluconazole tablets are indicated for treating vaginal candidiasis, oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and systemic Candida infections. They are also used prophylactically to reduce candidiasis incidence in patients undergoing bone marrow transplantation with cytotoxic therapy or radiation.

    • fluconazole

      (Fluconazole)
      Zhejiang Poly Pharm. Co., Ltd.
      Usage: Fluconazole for oral suspension is indicated for treating oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and systemic Candida infections. It is also used prophylactically to reduce candidiasis incidence in patients undergoing bone marrow transplantation with chemotherapy or radiation.

    • micafungin

      (Micafungin)
      Par Pharmaceutical, Inc.
      Usage: Micafungin for Injection is indicated for the treatment of candidemia, acute disseminated candidiasis, Candida peritonitis, abscesses, and esophageal candidiasis in patients aged 4 months and older. It is also used for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

    • vfend

      (voriconazole)
      Roerig
      Usage: VFEND is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older. Testing for causative organisms should precede therapy, but treatment may begin before results are available.

    • voriconazole

      (voriconazole)
      Sandoz Inc
      Usage: Voriconazole tablets are indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older. Fungal cultures should guide therapy adjustments post-initiation.

    • voriconazole

      (voriconazole)
      Zydus Lifesciences Limited
      Usage: Voriconazole tablets are indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious infections caused by Scedosporium and Fusarium species in patients aged 2 years and older. Initial therapy may begin before laboratory results are available, but should be adjusted based on findings.

    • voriconazole

      (voriconazole)
      Viona Pharmaceuticals Inc
      Usage: Voriconazole tablets are indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older, particularly those intolerant or refractory to other therapies.